Alector, Inc. (ALEC) — Stock Score Summary

Alector, Inc. (ALEC) has a MoatMap StockRank of 12/100 based on Quality (13/100), Value (30/100), and Momentum (53/100) factor scores. The current signal is STRONG SELL. Alector is a clinical-stage biopharmaceutical company with highly speculative cash flows. It fails the Warren Buffett lens of owner earnings and the Terry Smith lens of avoiding pre-revenue, high-risk clinical turnarounds.

Alector, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases. The company's research focuses on modulating the immune system in the brain to treat conditions like Alzheimer's and Parkinson's. Its pioneering approach to neuroimmunology offers a unique therapeutic strategy in a field with significant unmet medical needs.

Key Financial Metrics

Price$1.77
Market Cap$239M
P/E (Forward)-2.59
Price/Book19.26
Return on Equity-238.9%
Return on Invested Capital-69.7%
Debt/Equity332.77
Gross Margin0.0%
Operating Margin-2382.3%
Revenue Growth-71.5%
Free Cash Flow$-119M

Alector, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Alector, Inc.’s (ALEC) StockRank?
MoatMap’s StockRank for Alector, Inc. (ALEC) is 12/100, with a Strong Sell signal. It is a composite of Quality (13), Value (30), and Momentum (53) factor ranks across MoatMap’s 19,000+ stock universe.
Does Alector, Inc. have an economic moat?
Alector, Inc. (ALEC) has a Quality factor score of 13/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Alector, Inc. a buy, hold, or sell?
MoatMap’s current signal for Alector, Inc. (ALEC) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Alector, Inc. in?
Alector, Inc. (ALEC) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksALEC deep dive reportAI ChampionsHow we score stocksSense-check another stock